Prospective Study of NanoTite Implants Placed Into Fresh Sinus-Lift Augmentation Sites (VSSL)
A Prospective, Randomized-Controlled, Multicenter Study of NanoTite Implants Placed Into Fresh Sinus Lift Augmentation Sites
1 other identifier
interventional
122
1 country
1
Brief Summary
This prospective, randomized-controlled, clinical study evaluates the ability of the NanoTite implant system to achieve integration and provide long-term support of a prosthesis when placed immediately in fresh sinus augmentation material. Control cases will be those where the sinus augmentation material is allowed four months of healing prior to NanoTite implant placement. In addition to implant performance, radiographic evidence of crestal bone regressive modeling will be used to evaluate differences between test and control cases. Study (null) hypothesis: The implants placed into sinus augmentation sites at the time of grafting will have the same integration success and maintenance of integration as for the implants placed after four months of graft healing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 9, 2008
CompletedFirst Posted
Study publicly available on registry
July 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedResults Posted
Study results publicly available
October 11, 2013
CompletedJuly 13, 2023
July 1, 2023
5.8 years
July 9, 2008
August 6, 2013
July 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Implants Not Mobile (Not Failing) at End of 3 Years
All surviving implants at the end of study (3 years)
3 years
Other Outcomes (1)
Crestal Bone Loss (Measured Value of Bone Level Around the Dental Implant)
3 year
Study Arms (2)
Dental implant (Osseotite)
ACTIVE COMPARATORDental implants placed simultaneously with graft augmentation material.
Control group
NO INTERVENTIONDental implants placed into graft augmentation material that has four months to heal.
Interventions
Root form titanium dental implant
Eligibility Criteria
You may qualify if:
- Patients of either sex and any race greater than 18 years of age
- Patients for whom a decision has already been made to augment one or both maxillary sinuses for the purpose of placing dental implants in a maxillary ridge no less than 3 mm high and no greater than 5 mm in height
- Patients must be physically able to tolerate conventional surgical and restorative procedures.
- Patients must agree to be evaluated for each study visit, especially the yearly follow-up visit
You may not qualify if:
- Patients with active infection or severe inflammation in the areas intended for implant placement.
- Patients with a \>10 cigarettes per day smoking habit.
- Patients with uncontrolled diabetes mellitus.
- Treatment with therapeutic radiation to the head within the past 12 months.
- Patients who are pregnant at the screening visit.
- Patients with evidence of severe para-functional habits such as bruxing or clenching.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ZimVielead
Study Sites (1)
Università "G. d' Annunzio" Chieti-Pescara
Chieti, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Research Manager
- Organization
- Biomet 3i LLC
Study Officials
- PRINCIPAL INVESTIGATOR
Sergio Caputi, DDS
Director del Dipartimento di Scienze Odontostomatologiche
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2008
First Posted
July 11, 2008
Study Start
September 1, 2006
Primary Completion
July 1, 2012
Study Completion
August 1, 2012
Last Updated
July 13, 2023
Results First Posted
October 11, 2013
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share